BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36807890)

  • 1. Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases.
    Chen Q; Li K; Rhodin KE; Masoud SJ; Lidsky ME; Cai J; Wei Q; Luo S; Zhao H
    J Surg Oncol; 2023 May; 127(6):945-955. PubMed ID: 36807890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment.
    Lewis A; Raoof M; Ituarte PHG; Williams J; Melstrom L; Li D; Lee B; Singh G
    Ann Surg; 2019 Dec; 270(6):1131-1137. PubMed ID: 29746336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection of the Primary Tumor Improves the Survival of Patients With Stage IV Gastric Neuroendocrine Carcinoma.
    Li Z; Ren H; Wang T; Zhang X; Zhao L; Sun C; Niu P; Guo C; Chen Y; Zhao D
    Front Oncol; 2022; 12():930491. PubMed ID: 35912176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection of the primary tumor improves the prognosis of gastrointestinal neuroendocrine neoplasms with liver metastases: mutual validation based on SEER database and institutional data.
    Liu Y; Wang Z; Lin Q; Cui R; Tang W; Li G; Wang Z
    BMC Gastroenterol; 2023 Nov; 23(1):408. PubMed ID: 37993767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of primary tumor resection and metastasectomy among gastroentero-pancreatic neuroendocrine tumors with liver metastases only on survival.
    Chen Q; Li K; Rhodin KE; Bartholomew AJ; Lidsky ME; Wei Q; Cai J; Luo S; Zhao H
    HPB (Oxford); 2024 Jan; 26(1):125-136. PubMed ID: 37806829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas.
    Mao R; Li K; Cai JQ; Luo S; Turner M; Blazer D; Zhao H
    Ann Surg; 2021 Aug; 274(2):e126-e133. PubMed ID: 31478977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
    Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
    Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary tumor resection and lymph node dissection improve survival in
    Wu C; Zhang X; Wang T; Zhou H; Guo C; Chen Y; Zhao D
    Transl Cancer Res; 2020 May; 9(5):3312-3323. PubMed ID: 35117698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of Primary Gastrointestinal Neuroendocrine Tumor Among Patients with Non-Resected Metastases Is Associated with Improved Survival: A SEER-Medicare Analysis.
    Tsilimigras DI; Hyer JM; Paredes AZ; Ejaz A; Cloyd JM; Beane JD; Dillhoff M; Tsung A; Pawlik TM
    J Gastrointest Surg; 2021 Sep; 25(9):2368-2376. PubMed ID: 33403563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Postoperative Chemotherapy on the Survival of Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinoma.
    Schmitz R; Mao R; Moris D; Strickler JH; Blazer DG
    Ann Surg Oncol; 2021 Jan; 28(1):114-120. PubMed ID: 32556871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of liver resection on survival outcomes of hepatocellular carcinoma patients with extrahepatic metastases: A propensity score matching study.
    Mao K; Yan Y; Zhang J; Wang J; Wang R; Ling X; Liu Y; Lau WY; Jiang S; Liu J; Xiao Z
    Cancer Med; 2018 Sep; 7(9):4475-4484. PubMed ID: 30117307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Primary Tumor Resection on Mortality in Patients with Stage IV Colorectal Cancer with Unresectable Metastases: A Multicenter Retrospective Cohort Study.
    Kawamura H; Ogawa Y; Yamazaki H; Honda M; Kono K; Konno S; Fukuhara S; Yamamoto Y
    World J Surg; 2021 Oct; 45(10):3230-3239. PubMed ID: 34223985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Tumor Resection Offers Survival Benefit in Patients with Metastatic Midgut Neuroendocrine Tumors.
    Polcz M; Schlegel C; Edwards GC; Wang F; Tan M; Kiernan C; Solórzano CC; Idrees K; Parikh A; Bailey CE
    Ann Surg Oncol; 2020 Aug; 27(8):2795-2803. PubMed ID: 32430752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas.
    Galleberg RB; Knigge U; Tiensuu Janson E; Vestermark LW; Haugvik SP; Ladekarl M; Langer SW; Grønbæk H; Österlund P; Hjortland GO; Assmus J; Tang L; Perren A; Sorbye H
    Eur J Surg Oncol; 2017 Sep; 43(9):1682-1689. PubMed ID: 28522174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine Carcinomas.
    Lamarca A; Walter T; Pavel M; Borbath I; Freis P; Nuñez B; Childs A; McNamara MG; Hubner RA; Garcia-Carbonero R; Meyer T; Valle JW; Barriuso J
    J Natl Cancer Inst; 2017 Jan; 109(5):. PubMed ID: 28130474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Primary Tumor Resection on Survival in Asymptomatic Colorectal Cancer Patients With Unresectable Metastases.
    Doah KY; Shin US; Jeon BH; Cho SS; Moon SM
    Ann Coloproctol; 2021 Apr; 37(2):94-100. PubMed ID: 33979907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.
    Yu G; Liu S; Wang Z; Liu Q; Ren H; Hu W
    BMC Surg; 2024 Mar; 24(1):85. PubMed ID: 38475759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of surgery for gastric cancer with distant metastases: a retrospective study from the SEER database.
    Chen J; Kong Y; Weng S; Dong C; Zhu L; Yang Z; Zhong J; Yuan Y
    Oncotarget; 2017 Jan; 8(3):4342-4351. PubMed ID: 28008147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on "Primary tumor resection improves survival of gastrointestinal neuroendocrine carcinoma patients with nonresected liver metastases".
    Li X; Liu L
    J Surg Oncol; 2024 Feb; 129(2):449-450. PubMed ID: 37818827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.